David J. Woodhouse - Jan 16, 2024 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Valerie Pierce, Attorney-in-Fact
Stock symbol
NGM
Transactions as of
Jan 16, 2024
Transactions value $
-$17,463
Form type
4
Date filed
1/18/2024, 06:01 PM
Previous filing
Nov 8, 2023
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Tax liability -$17.5K -13K -9% $1.34 132K Jan 16, 2024 Direct F1
holding NGM Common Stock 80K Jan 16, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
F2 Shares held by The Woodhouse Family Trust 9/8/05.